Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

ABLAVAR Drug Profile

« Back to Dashboard

What is the patent landscape for Ablavar, and when can generic versions of Ablavar launch?

Ablavar is a drug marketed by Lantheus Medcl and is included in one NDA. There is one patent protecting this drug.

This drug has forty-one patent family members in twenty-six countries.

The generic ingredient in ABLAVAR is gadofosveset trisodium. Additional details are available on the gadofosveset trisodium profile page.

Summary for Tradename: ABLAVAR

Clinical Trials: see list6
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ABLAVAR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medcl
gadofosveset trisodium
SOLUTION;INTRAVENOUS021711-001Dec 22, 2008DISCNNoNo6,676,929► SubscribeY ► Subscribe
Lantheus Medcl
gadofosveset trisodium
SOLUTION;INTRAVENOUS021711-002Dec 22, 2008DISCNNoNo6,676,929► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus